Clinical Trial Update: Prolonged Outcomes After Nitric Oxide (PrONOx)

View source ↗

Summary

A completed clinical trial (PrONOx) investigates prolonged outcomes after inhaled nitric oxide in infants at risk for bronchopulmonary dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Nitric oxide (inhaled) (nitric oxide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Lung Diseases, Bronchopulmonary Dysplasia | Status: COMPLETED